From: Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
 | Overall | Men | Women | |||
---|---|---|---|---|---|---|
Measure | Apoptosis (n, Lower/upper half) | Adjusted OR1(95% CI) | Apoptosis (n, Lower/upper half) | Adjusted OR1(95% CI) | Apoptosis (n, Lower/upper half) | Adjusted OR1(95% CI) |
C-Peptide | Â | Â | Â | Â | Â | Â |
Quartile 1 | 12/16 | 1.0 (Referent) | 6/7 | 1.0 (Referent) | 6/9 | 1.0 (Referent) |
Quartile 2 | 26/20 | 3.1 (1.0, 9.5) | 9/11 | 4.4 (0.7, 30.0) | 17/9 | 3.9 (0.9, 16.1) |
Quartile 3 | 33/24 | 2.7 (0.9, 8.1) | 17/9 | 7.0 (1.1,45.3) | 16/15 | 1.9 (0.5, 7.3) |
Quartile 4 | 54/45 | 2.5 (0.9, 7.1) | 30/21 | 6.3 (1.1, 36.7) | 24/24 | 1.5 (0.4, 5.5) |
P trend | Â | 0.0465 | Â | 0.04 | Â | 0.30 |
IGFBP-1 | Â | Â | Â | Â | Â | Â |
Quartile 1 | 51/35 | 1.0 (Referent) | 24/13 | 1.0 (Referent) | 27/22 | 1.0 (Referent) |
Quartile 2 | 44/33 | 0.9 (0.5, 1.9) | 23/16 | 0.9 (0.3, 2.6) | 21/17 | 1.0 (0.4, 2.5) |
Quartile 3 | 22/19 | 0.9 (0.4, 2.1) | 12/12 | 0.5 (0.1, 1.6) | 10/7 | 1.4 (0.4, 4.9) |
Quartile 4 | 8/18 | 0.3 (0.1, 1.0) | 3/7 | 0.2 (0.03, 1.2) | 5/11 | 0.4 (0.1, 1.5) |
P trend | Â | 0.10 | Â | 0.07 | Â | 0.44 |
Insulin | Â | Â | Â | Â | Â | Â |
Quartile 1 | 11/14 | 1.0 (Referent) | 6/8 | 1.0 (Referent) | 5/6 | 1.0 (Referent) |
Quartile 2 | 25/17 | 1.6 (0.5, 5.1) | 16/5 | 2.3 (0.4, 13.1) | 9/12 | 1.1 (0.2, 5.5) |
Quartile 3 | 33/25 | 1.3 (0.4, 3.9) | 17/13 | 0.7 (0.1, 3.4) | 16/12 | 1.7 (0.3, 8.5) |
Quartile 4 | 40/32 | 1.5 (0.5, 4.4) | 17/10 | 1.0 (0.2, 4.9) | 23/22 | 1.6 (0.4, 7.1) |
P trend | Â | 0.46 | Â | 0.99 | Â | 0.53 |